Markets:

Overview

News

Currencies

International

Treasuries

Masimo Corporation - Common Stock (NQ:MASI)

178.81 +0.17 (+0.10%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Masimo Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

24 25 Next >

Masimo Issues Statement on California Jury Verdict Finding Patent Infringement by Apple and Awarding Masimo $634 Million in Damages

November 14, 2025

From Masimo

Via Business Wire

5 Insightful Analyst Questions From Masimo’s Q3 Earnings Call

November 11, 2025

Masimo’s third quarter results for 2025 were met with a significant negative market reaction, despite the company surpassing Wall Street’s revenue and adjusted profit expectations. Management...

Via StockStory

Topics Earnings

MASI Q3 Deep Dive: Margin Expansion and Product Pipeline Shape Outlook

November 05, 2025

Medical tech company Masimo (NASDAQ:MASI) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 8.2% year on year to $371.5 million. The company expects the full year’s...

Via StockStory

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Masimo Earnings Preview ↗

November 03, 2025

Via Benzinga

How Is The Market Feeling About Masimo? ↗

September 05, 2025

Via Benzinga

Masimo’s (NASDAQ:MASI) Q3 Sales Top Estimates

November 04, 2025

Medical tech company Masimo (NASDAQ:MASI) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 8.2% year on year to $371.5 million. The company expects the full year’s...

Via StockStory

Masimo Reports Third Quarter 2025 Results

November 04, 2025

From Masimo Corporation

Via Business Wire

Earnings To Watch: Masimo (MASI) Reports Q3 Results Tomorrow

November 02, 2025

Medical tech company Masimo (NASDAQ:MASI) will be reporting results this Tuesday after market hours. Here’s what you need to know.

Via StockStory

1 Unprofitable Stock with Exciting Potential and 2 We Brush Off

October 31, 2025

Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.

Via StockStory

Topics Electric Vehicles

$1000 Invested In Masimo 10 Years Ago Would Be Worth This Much Today ↗

October 24, 2025

Via Benzinga

Halper Sadeh LLC Encourages Masimo Corporation Shareholders to Contact the Firm to Discuss Their Rights

October 23, 2025

From Halper Sadeh LLC

Via Business Wire

Masimo to Report Third Quarter 2025 Financial Results after Market Close on Tuesday, November 4

October 21, 2025

From Masimo

Via Business Wire

Recent Report Shows That Rep. Kevin Hern Sold Up to $200K Worth of Accenture Stock ↗

October 17, 2025

Via Benzinga

DexCom, Masimo, Integer Holdings, The Pennant Group, and Organon Stocks Trade Down, What You Need To Know

October 10, 2025

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Via StockStory

Topics Economy Government World Trade

1 Cash-Producing Stock Worth Your Attention and 2 We Brush Off

October 10, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

Masimo to Host Investor Day on December 3, 2025

October 09, 2025

From Masimo

Via Business Wire

In Feasibility Study for Large, Prospective, Real-World Trial, Masimo SET® Performed Accurately on Critically Ill Adult ICU Patients of All Skin Tones

October 07, 2025

From Masimo

Via Business Wire

3 Healthcare Stocks We Think Twice About

October 03, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the...

Via StockStory

Topics Stocks

3 Reasons MASI is Risky and 1 Stock to Buy Instead

October 02, 2025

Over the past six months, Masimo’s shares (currently trading at $142) have posted a disappointing 17.2% loss, well below the S&P 500’s 18.4% gain. This might have investors contemplating their next...

Via StockStory

Topics Stocks

Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape

September 30, 2025

September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Masimo, Integra LifeSciences, CONMED, IQVIA, and Charles River Laboratories Shares Are Soaring, What You Need To Know

September 30, 2025

A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. The Trump administration is...

Via StockStory

Topics Government World Trade

Here's How Much $100 Invested In Masimo 10 Years Ago Would Be Worth Today ↗

September 29, 2025

Masimo (NASDAQ: MASI) has outperformed the market over the past 10 years by 1.12% on an annualized basis producing an average annual return of 13.99%. Currently, Masimo has a market capitalization of...

Via Benzinga

Masimo Completes Sale of Consumer Audio Business to HARMAN International

September 23, 2025

From Masimo

Via Business Wire

MASIMO INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Masimo Corporation - MASI

September 18, 2025

From Kahn Swick & Foti, LLC

Via GlobeNewswire

New Study Finds That Using Masimo Technologies to Continuously Monitor General Floor Patients Reduces Costs

September 17, 2025

From Masimo

Via Business Wire

Masimo Announces Expansion of Strategic Partnership with Philips

September 11, 2025

From Masimo

Via Business Wire

3 of Wall Street’s Favorite Stocks with Questionable Fundamentals

September 02, 2025

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,...

Via StockStory

Masimo to Present in the Wells Fargo Healthcare Conference

August 28, 2025

From Masimo

Via Business Wire

1 Small-Cap Stock Worth Your Attention and 2 Facing Challenges

August 27, 2025

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

24 25 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.